Prognostic impact of PRDM16 expression in acute myeloid leukemia with normal cytogenetics.
Xin XiangQiongyu LuXiaoyu XuPing CaiSuning ChenJin-Lan PanZhao ZengPublished in: Hematology (Amsterdam, Netherlands) (2022)
PRDM16 is significantly associated with FLT3-ITD and DNMT3A mutation and WT1 expression and serves as a potential prognostic biomarker in CN-AML.